Gordon Bradley Cole
Independent DirectorMr. Gordon Bradley Cole, also known as Brad, serves as the Chief Financial Officer, Head of Audit and Director of GENOMIC LIFE, INC. Mr. Cole has been Independent Director at Kiniksa Pharmaceuticals International, plc (formerly known as Kiniksa Pharmaceuticals, Ltd.) since July 27, 2020. Mr. Cole serves as Independent Director for Castle Biosciences, Inc. since December 06, 2018. Mr. Cole served as General Manager of Precision Oncology of Exact Sciences Corporation until April 2020. He has been General Manager of Precision Oncology at Genomic Health Inc. from November 8, 2019 to April 2020. He served as the Chief Financial Officer of Genomic Health Inc. from June 13, 2014 to November 8, 2019. Mr. Cole was the Chief Operating Officer of Genomic Health Inc. since January 2009 until March 2018 and its Secretary since April 22, 2014. He served as Executive Advisor of Exact Sciences Corporation, or Exact Sciences, from April 2020 to September 2020. He served as Secretary of Genomic Health Inc. since February 2005 until July 26, 2012. He served as the Executive Vice President since July 2004 until 2008 and Chief Financial Officer from July 2004 to January 3, 2011 at Genomic Health Inc. and also served as its Principal Accounting Officer until January 3, 2011. He served as Executive Vice President of Operations from Genomic Health Inc. from January 2008 until January 2009. He served in various positions at Guidant Corporation and served as Vice President of Finance and Business Development of the Endovascular Solutions Group from January 2001 to May 2004 and as Vice President and General Manager of the Vascular Surgery Business Unit from December 1998 to December 2000 and as Vice President, Finance and IT Systems of the Cardiac and Vascular Surgery Group from December 1997 to November 1998. He also served as Principal Accounting Officer of Endovascular Technologies. From July 1994 to December 1997, Mr. Cole served as Vice President of Finance and Chief Financial Officer of Endovascular Technologies, Inc., a medical device company that was acquired by Guidant Corporation. From December 1988 to February 1994, he served as Vice President of Finance and Chief Financial Officer of Applied Biosystems Incorporated, a life sciences systems company. In 2017, Mr. Cole was recognized for his leadership and named Bay Area CFO of the Year by the San Francisco Business Times. He has been a member of the Biola University Board of Trustees since 2002. From December 1988 to February 1994, he served as Vice President, Finance and Chief Financial Officer of Applied Biosystems Incorporated, a life sciences systems company. Mr. Cole holds a B.S. in Business and accounting from Biola University and an M.B.A. from San Jose State University.
Positions
- Company NameCastle Biosciences, Inc.Stock CodeCSTLPositionIndependent DirectorColleagues
- DJDerek J. MaetzoldFounder, CEO, President & Director
- DMDaniel Mark BradburyIndependent Chairman of the Board
- FSFrank StokesCFO & Treasurer
- KMKristen M. OelschlagerChief Operating Officer
- TWTobin W. JuvenalChief Commercial Officer
- CZCamilla ZuckeroVice President of Investor Relations & Corporate Affairs
- TPTiffany P. OlsonIndependent Director
- EGEllen GoldbergIndependent Director
